pulmonary disease, chronic obstructive

Showing 51 - 75 of 876

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (QBW251, Placebo, COPD maintenance background therapy)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Andalusia, Alabama
  • +147 more
Jul 27, 2022

Smart Textile Sensor System for Health Monitoring

Recruiting
  • Heart Disease Chronic
  • +3 more
  • Nanowear SimpleSense Wearable monitoring device
  • Atlanta, Georgia
  • +2 more
Jul 22, 2022

Emphysema, Pulmonary Disease, Chronic Obstructive Trial in Porto Alegre, Heidelberg, Groningen (IAB System)

Recruiting
  • Emphysema
  • Pulmonary Disease, Chronic Obstructive
  • IAB System
  • Porto Alegre, Brazil
  • +2 more
Jul 15, 2022

(In)Voluntary Assessed Quadriceps Muscle Endurance in COPD

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Jun 16, 2022

    Chronic Obstructive Pulmonary Disease (COPD) Participants

    Recruiting
    • Pulmonary Disease, Chronic Obstructive
    • prospective observational cohort study
    • Hannover, Niedersachsen, Germany
      GSK Investigational Site
    Jun 20, 2022

    Pulmonary Disease, Chronic Obstructive Trial in United States (Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy),

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Stiolto Respimat
    • +3 more
    • Mobile, Alabama
    • +89 more
    May 24, 2022

    Early Intervention Efficacy in COPD

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Nara, Japan
      Nara Medical University
    May 24, 2022

    Alzheimer, Late Onset, Stroke, Heart Failure Trial in Yilan (Health Education Manual, manual)

    Completed
    • Alzheimer Disease, Late Onset
    • +7 more
    • Health Education Manual
    • manual
    • Yilan, Taiwan
      Wen-Shiou Pan
    Jun 6, 2022

    Pulmonary Disease, Chronic Obstructive, Airway Disease, COPD Exacerbation Trial in San Francisco (Ozone exposure)

    Active, not recruiting
    • Pulmonary Disease, Chronic Obstructive
    • +4 more
    • Ozone exposure
    • San Francisco, California
    • +2 more
    Jun 6, 2022

    Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)

    Not yet recruiting
    • Pulmonary Disease, Chronic Obstructive
    • (no location specified)
    May 26, 2022

    Acute Exacerbation of COPD, Lung Diseases, Lung Diseases, Obstructive Trial in Hong Kong (The intervention (CRP-guided) group)

    Not yet recruiting
    • Acute Exacerbation of COPD
    • +4 more
    • The intervention (CRP-guided) group
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    May 16, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Gastonia, Charleston (Self-management support)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Self-management support
    • Gastonia, North Carolina
    • +1 more
    May 16, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Pessac (quadricipital biopsy)

    Not yet recruiting
    • Pulmonary Disease, Chronic Obstructive
    • quadricipital biopsy
    • Pessac, France
      Hôpital Haut-Lévêque - CHU de Bordeaux
    May 12, 2022

    Pulmonary Disease, Chronic Obstructive, Pneumonia, Bacterial Trial in Ann Arbor (Bronchoscopy with bilateral bronchoalveolar

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Pneumonia, Bacterial
    • Bronchoscopy with bilateral bronchoalveolar lavages
    • Ann Arbor, Michigan
      VA Ann Arbor Healthcare System
    Apr 26, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Bad Reichenhall (Pulmonary Rehabilitation (usual care), Pulmonary Rehabilitation

    Recruiting
    • Pulmonary Disease, Chronic Obstructive
    • Pulmonary Rehabilitation (usual care)
    • +2 more
    • Bad Reichenhall, Germany
      Klinik Bad Reichenhall der Deutschen Rentenversicherung Bayern S
    Apr 26, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Houston, Sugar Land, Webster (Balance Training, Breathing and Stretching

    Active, not recruiting
    • Pulmonary Disease, Chronic Obstructive
    • Balance Training
    • Breathing and Stretching Exercises
    • Houston, Texas
    • +3 more
    Apr 26, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Mus (mKOAH application)

    Recruiting
    • Pulmonary Disease, Chronic Obstructive
    • mKOAH application
    • Muş, Turkey
      Neşe ÖZDEMİR
    Apr 14, 2022

    Shared Adaptive, Multi-domain and Personalised Prediction and

    Recruiting
    • Pulmonary Disease, Chronic Obstructive
    • +2 more
      • Enschede, Netherlands
        Medisch Spectrum Twente
      Apr 11, 2022

      Wellinks Effect on COPD Hospital Readmissions

      Not yet recruiting
      • COPD
      • +4 more
      • Wellinks
      • (no location specified)
      Apr 14, 2022

      Chronic Obstructive Pulmonary Disease and Eosinophilia Among

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Minimal questionnaire
      • +5 more
      • Londrina, Paraná, Brazil
      • +3 more
      Apr 11, 2022

      South Korea Using Medical Records to Look at Different

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Long-acting Muscarinic Antagonists (LAMA)
      • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
      • Seoul, Korea, Republic of
        Konkuk University Medical Center
      Feb 8, 2022

      Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • +4 more
      • Lifestyle Intervention
      • Birmingham, Alabama
      • +38 more
      Mar 10, 2022

      Acute Exacerbations of Chronic Obstructive Pulmonary Disease in

      Active, not recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Prospective observational cohort study
      • Fukuoka, Japan
      • +12 more
      Apr 4, 2022

      Pulmonary Disease, Chronic Obstructive Trial in Chapel Hill, Winston-Salem (Albuterol eMDPI DS)

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Albuterol eMDPI DS
      • Chapel Hill, North Carolina
      • +1 more
      Mar 30, 2022

      Vahelva Respimat Regulatory Post-marketing Surveillance in

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Vahelva® Respimat® (Tiotropium + Olodaterol fixed dose combination)
      • One Or Multiple Sites, Korea, Republic of
        Chonnam National University Hospital
      Feb 28, 2022